Mild cognitive impairment and its management in older people

Clinical Interventions in Aging

Volumn 10, Issue , 2015, Pages 687-693

  Eshkoor, Sima Ataollahi ^a   Hamid, Tengku Aizan ^a   Mun, Chan Yoke ^a   Ng, Chee Kyun ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

AD; Alzheimer s disease; Cognition; Dementia; MCI

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; AL 208; ALPHA TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKER; C 105; CELECOXIB; CITICOLINE; CURCUMIN; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; GALANTAMINE; GINKGO BILOBA EXTRACT; MEM 1414; MEMANTINE; METABOTROPIC RECEPTOR ANTAGONIST; NIMODIPINE; OMEGA 3 FATTY ACID; PHOSPHODIESTERASE INHIBITOR; PIRACETAM; ROFECOXIB; SEROTONIN ANTAGONIST; SGS 518; TESTOSTERONE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; ANTIOXIDANT; CHOLINESTERASE INHIBITOR;

AEROBIC EXERCISE; AGING; AUTONOMIC TRAINING; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; EATING HABIT; HUMAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; MEDITERRANEAN DIET; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PATIENT CARE; PSYCHOTHERAPY; REVIEW; SOCIAL MEDICINE; THINKING; TREATMENT INDICATION; AGED; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; DIET; DISEASE COURSE; EXERCISE; GENETIC PREDISPOSITION; HUMAN RELATION; PREVALENCE; RISK FACTOR;

AGED; ANTIOXIDANTS; BIOMARKERS; CHOLINESTERASE INHIBITORS; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; DIET; DISEASE PROGRESSION; EXERCISE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERPERSONAL RELATIONS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS;

EID: 84928162358     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S73922     Document Type: Review

References (52)

1. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003;2:15-21.
2. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225-228.
3. Kester JD, Benjamin AS, Castel AD, Craik FIM. Memory in elderly people. In: Baddeley AD, Kopelman MD, Wilson BA, editors. The handbook of memory disorder. 2nd ed. London: Wiley; 2002:543-567.
4. Etgen T, Sander D, Bickel H, Förstl H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int. 2011;108:743-750.
5. Woodford HJ, George J. Cognitive assessment in the elderly: a review of clinical methods. QJM. 2007;100:469-484.
6. Pinto C, Subramanyam AA. Mild cognitive impairment: The dilemma. Indian J Psychiatry. 2009;51 Suppl 1:S44-S51.
7. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
8. Tricco AC, Soobiah C, Lillie E, et al. Use of cognitive enhancers for mild cognitive impairment: protocol for a systematic review and network meta-analysis. Syst Rev. 2012;1:25.
9. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet. 2006;367:1262-1270.
10. Razali R, Baharudin A, Jaafar NRN, et al. Factors Associated with Mild Cognitive Impairment among Elderly Patients Attending Medical Clinics in Universiti Kebangsaan Malaysia Medical Centre. Sains Malaysiana. 2012;41:641-647.
11. Odawara T. Cautious notification and continual monitoring of patients with mild cognitive impairment. Psychogeriatrics. 2012;12:131-132.
12. Albert MS, Blacker D. Mild cognitive impairment and dementia. Annu Rev Clin Psychol. 2006;2:379-388.
13. Irish M, Lawlor BA, Coen RF, O'Mara SM. Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation. BMC Neurosci. 2011;12:80.
14. Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17:101-118.
15. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change - report of a national institute of mental health work group. Dev Neuropsychol. 1986;2(4):261-276.
16. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
17. Kluger A, Gianutsos JG, Golomb J, Wagner A Jr, Wagner D, Scheurich S. Clinical features of MCI: motor changes. Int Psychogeriatr. 2008;20:32-39.
18. Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement. 2012;8:14-21.
19. Wada-Isoe K, Uemura Y, Nakashita S, et al. Prevalence of Dementia and Mild Cognitive Impairment in the Rural Island Town of Ama-cho, Japan. Dement Geriatr Cogn Disord Extra. 2012;2:190-199.
20. Sosa AL, Albanese E, Stephan BC, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS medicine. 2012;9:e1001170.
21. Rashid A, Azizah A, Rohana S. Cognitive impairment among the elderly Malays living in rural Malaysia. Med J Malaysia. 2012;67:187-189.
22. Reitz C, Mayeux R. Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimers Dis. 2010;19:229-251.
23. Eshkoor SA, Hamid TA, Nudin SS, Mun CY. Does substance abuse contribute to further risk of falls in dementia. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2014;21:317-324.
24. Visser PJ. Mild Cognitive Impairment. Maastricht: Neuropsych Publishers. 2000;13:496-497.
25. Bruscoli M, Lovestone S. Is MCI really just Is MCI really just early dementia? A systematic review of conversion early dementia? A systematic review of conversion studies. Int Psychogeriatr. 2004;16:129-140.
26. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-194.
27. Panza F, D'Introno A, Colacicco AM, et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriat Psychiatry. 2005;13:633-644.
28. Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006;189:399-404.
29. Smith GE, Petersen RC, Parisi JE, et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol C. 1996;3:141-147.
30. Nizamuddin M. Population ageing: policy responses to population ageing in Asia and the Pacific. Fifth Asian and Pacific Population Conference. 2000;2025:95.
31. Ellison JM. A 60-year-old woman with mild memory impairment: review of mild cognitive impairment. JAMA. 2008;300:1566-1574.
32. Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol. 2007;64:416-420.
33. Eshkoor SA, Hamid TA, Nudin SS, Mun CY. The effects of sleep quality, physical activity, and environmental quality on the risk of falls in dementia. Am J Alzheimers Dis Other Demen. 2013;28:403-407.
34. Austrom MG, Lu Y. Long term caregiving: helping families of persons with mild cognitive impairment cope. Curr Alzheimer Res. 2009;6:392-398.
35. Lam LC, Tam CW, Lui VW, et al. Screening of mild cognitive impairment in Chinese older adults - a multistage validation of the Chinese abbreviated mild cognitive impairment test. Neuroepidemiology. 2008;30:6-12.
36. Song F, Poljak A, Smythe GA, Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev. 2009;61:69-80.
37. Trojanowski JQ, Vandeerstichele H, Korecka M, et al. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010;6:230-238.
38. Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg. 2005;107:165-173.
39. Blennow K. CSF biomarkers for mild cognitive impairment. J Intern Med. 2004;256:224-234.
40. Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY). 2012;4:590-605.
41. Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol. 2004;3:246-248.
42. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
43. Dai DL. Mild Cognitive Impairment: A Clinical Approach. Med Bull. 2008;13(9):11-16.
44. Farina N, Isaac MG, Clark AR, Rusted J, Tabet N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2012;11:CD002854.
45. Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;311:33-44.
46. Wong SH, Rajikan R, Das S, et al. Antioxidant intake and mild cognitive impairment among elderly people in Klang Valley: a pilot study. Sains Malaysiana. 2010;39:689-696.
47. Dale W, Hougham GW, Hill EK, Sachs GA. High interest in screening and treatment for mild cognitive impairment in older adults: A pilot study. J Am Geriatr Soc. 2006;54:1388-1394.
48. Håkansson K, Rovio S, Helkala EL, et al. Association between mid-life marital status and cognitive function in later life: population based cohort study. BMJ. 2009;339:b2462.
49. Chenderes RM, Podea DM, Nanu PD, Mila C. P03-95 Mild cognitive impairment and intellectual activity in the elderly. Eur Psychiatry. 2009;24:S1094.
50. Roberts RO, Geda YE, Cerhan JR, et al. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;29:413-423.
51. Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol. 2010;67:80-86.
52. Ambigga D, Suthahar A, Ramli A, Ng K, Radziah A, Marymol K. Diagnosis and Management of Mild Cognitive Impairment in the Community: What is the Role of Primary Care Physician? Malays Fam Physician. 2011;6:74-78.